Skip to main content

Table 2 Surgery and postoperative course

From: Palliative bypass surgery for patients with advanced pancreatic adenocarcinoma: experience from a tertiary center

 n = 42
Laparoscopy/open (ratio)22/20 (1.1)
GJ only, n (%)31 (73.8)
Double bypass, n (%)11 (26.1)
Overall surgery time, min (mean ± SD)205 ± 78
Open gastro-jej time, min (mean ± SD)225 ± 71
Lap gastro-jej time, min (mean ± SD)162 ± 53
Double bypass surgery time, min (mean ± SD)270 ± 76
Patients requiring blood units in op, n (%)
Postoperative complications, n (%)
 Clavien-dindo ≥ 315 (35.7)
 Leak of anastomosis4 (9.5)
 Bleeding4 (9.5)
 DVT2 (4.76)
 Reoperation within 30 days6 (14.2)
Return to oral intake during post-op, n (%)34 (80.9)
Length of stay, days (mean ± SD, range)18.3 ± 22.2, 2–108
30 days mortality, n (%)7 (16.6)
60 days mortality, n (%)14 (33.3)
Returning to chemotherapy, n (%)18 (42.8)
Revisional palliative surgery, n (%)3 (7.14)
Palliation failure17 (40.5)
Overall survival (mean ± SD)172.8 ± 179.2
Median survival94.5
  1. DVT deep vein thrombosis, Lap laparoscopic, GJ gastrojejunostomy